Solutions

REUTERS by Kate Kelland                     April 21, 2015

LONDON, April 21 - Genetic sequence data on two of the deadliest yet most poorly understood viruses are to be made available to researchers worldwide in real time as scientists seek to speed up understanding of Ebola and MERS infections.

The project, led by British scientists with West African and Saudi Arabian collaboration, hopes to encourage laboratories around the world to use the live data -- updated as new cases emerge -- to find new ways to diagnose and treat the killer diseases, and ideally, ultimately, prevent them.

"The collective expertise of the world's infectious disease experts is more powerful than any single lab, and the best way of tapping into this...is to make data freely available as soon as possible," said Jeremy Farrar, director of the Wellcome Trust global health charity which is funding the work.

The gene sequences, already available for MERS cases and soon to come in the case of Ebola, will be posted on the website virological.org for anyone to see, access and use.

Read complete story.

http://af.reuters.com/article/topNews/idAFKBN0NC19W20150421?sp=true

DEVEX   by Molly Anders                                                                                         Feb. 19, 2015

...While the Ebola crisis is far from over, officials in government and the international development community have begun to think more the medium and long term. What can they learn from past post-crisis recovery initiatives?

  Health worker Alivin Davis poses next to the a board featuring handprints of Ebola survivors in Liberia. Photo by: Neil Brandvold / USAID / CC BY-NC

Devex asked aid officials and government officials from the region how to avoid some of the most common pitfalls that can plague — haunt, even — recovery and reconstruction efforts. Here are three of them.

1. Quality over quantity.

....By not paying closer attention to the economic effects of foreign aid on the local market, humanitarian groups hurt livelihoods and slowed reconstruction in the country.

2. Prioritize local ownership....

REUTERS     by Ben Hirschler                              Jan. 6, 2015
LONDON --Johnson & Johnson has started clinical trials of its experimental Ebola vaccine, which uses a booster from Denmark's Bavarian Nordic, making it the third such shot to enter human testing.

The initiation of the Phase I study in Britain, which had been expected about now, marks further progress in the race to develop a vaccine against a disease that has killed more than 8,000 people in West Africa since last year.

Two other experimental vaccines, one from GlaxoSmithKline and a rival from NewLink and Merck, are already in clinical development. However, the J&J vaccine offers a different approach, since it involves two separate injections.

Read complete story.

http://www.reuters.com/article/2015/01/06/us-health-ebola-vaccine-j-j-idUSKBN0KF0HH20150106

The Argus arrives with supplies and medical personnel to assist Serra Leone

 BBC                                                              Oct. 30, 2010

By AndrewHarding

FREETOWN, Sierra Leone--  A British Navy support ship ship has arrived in Sierra Leone to help deal with the deadly Ebola outbreak in the West African country.

Royal Fleet Auxiliary Argus is carrying food, medical equipment, three helicipeters and 32 pick-up trucks, to help keep hard-pressed Ebola treatment centres going.

Doctors, nurses and military personnel are also on board.

The BBC's Africa correspondent Andrew Harding said it would act as an offshore base for the aid effort. and described it as an "important moment".

Read complete story

http://www.bbc.com/news/uk-29836657